Literature DB >> 12236813

Influence of prior exposure to low-dose adapting radiation on radiation-induced teratogenic effects in fetal mice with varying Trp53 function.

R E J Mitchel1, J-A Dolling, J Misonoh, D R Boreham.   

Abstract

Teratogenesis in tails and limb digits of fetal mice with varying Trp53 status was examined after exposure of pregnant females to 4 Gy gamma radiation with and without a prior 30-cGy exposure. Prior low-dose exposure modified the teratogenic effects of radiation in a manner dependent upon Trp53 status and gestation time. A 4-Gy exposure on gestation day 11 resulted in tail shortening and digit abnormalities. A 30-cGy exposure 24 h prior to a 4-Gy radiation exposure on day 11 reduced the extent of both digit abnormalities and the tail-shortening effects in Trp53(+/+) fetuses and also reduced tail shortening in Trp53(+/-) fetuses, but to a lesser extent. However, the pre-exposure enhanced the tail-shortening effects of 4 Gy in Trp53(-/-) fetuses. In contrast, a 30-cGy exposure given 24 h prior to a 4-Gy exposure on gestation day 12 had no effect on the reduced tail length resulting from the 4-Gy exposure of Trp53(+/+) or Trp53(+/-) fetuses, but it partly protected Trp53(-/-) fetuses against reduced tail length. A 4-Gy exposure alone on day 12 did not result in any increase in the frequency of digit abnormalities in Trp53(-/-) fetuses so any protective effect of the preirradiation could not be detected. However, the preirradiation did result in protection against in digit abnormalities in Trp53(+/-) fetuses. We conclude that radiation-induced teratogenesis reflects both Trp53-dependent and independent processes that lead to apoptosis, and these respond differently to prior adapting doses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12236813     DOI: 10.1667/0033-7587(2002)158[0458:iopetl]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  12 in total

1.  Low-dose pretreatment for radiation therapy.

Authors:  Richard Blankenbecler
Journal:  Dose Response       Date:  2010-09-10       Impact factor: 2.658

2.  The adaptive response and protection against heritable mutations and fetal malformation.

Authors:  D R Boreham; J-A Dolling; C Somers; J Quinn; R E J Mitchel
Journal:  Dose Response       Date:  2006-08-25       Impact factor: 2.658

3.  Low doses of radiation are protective in vitro and in vivo: evolutionary origins.

Authors:  R E J Mitchel
Journal:  Dose Response       Date:  2006-08-19       Impact factor: 2.658

4.  Protective bystander effects simulated with the state-vector model.

Authors:  Helmut Schöllnberger; Peter M Eckl
Journal:  Dose Response       Date:  2007-06-26       Impact factor: 2.658

5.  Human lung cancer risks from radon - part I - influence from bystander effects - a microdose analysis.

Authors:  Bobby E Leonard; Richard E Thompson; Georgia C Beecher
Journal:  Dose Response       Date:  2010-08-20       Impact factor: 2.658

6.  The new radiobiology: returning to our roots.

Authors:  Brant A Ulsh
Journal:  Dose Response       Date:  2012-07-15       Impact factor: 2.658

7.  Human Lung Cancer Risks from Radon - Part II - Influence from Combined Adaptive Response and Bystander Effects - A Microdose Analysis.

Authors:  Bobby E Leonard; Richard E Thompson; Georgia C Beecher
Journal:  Dose Response       Date:  2010-01-19       Impact factor: 2.658

Review 8.  Systems biological and mechanistic modelling of radiation-induced cancer.

Authors:  M P Little; W F Heidenreich; S H Moolgavkar; H Schöllnberger; D C Thomas
Journal:  Radiat Environ Biophys       Date:  2007-12-21       Impact factor: 1.925

9.  Radiation risk prediction and genetics: the influence of the TP53 gene in vivo.

Authors:  R E J Mitchel
Journal:  Dose Response       Date:  2006-05-22       Impact factor: 2.658

10.  Human Lung Cancer Risks from Radon - Part III - Evidence of Influence of Combined Bystander and Adaptive Response Effects on Radon Case-Control Studies - A Microdose Analysis.

Authors:  Bobby E Leonard; Richard E Thompson; Georgia C Beecher
Journal:  Dose Response       Date:  2010-09-10       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.